These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9810972)

  • 1. Neuropsychological prediction of dementia in Parkinson's disease.
    Hughes TA; Read L; Mindham RH
    J Neurol Neurosurg Psychiatry; 1998 Nov; 65(5):804-5. PubMed ID: 9810972
    [No Abstract]   [Full Text] [Related]  

  • 2. Parkinson's disease dementia--an overlooked major illness.
    Libow LS
    Geriatrics; 2007 May; 62(5):11-2. PubMed ID: 17489642
    [No Abstract]   [Full Text] [Related]  

  • 3. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.
    Kasten M; Bruggemann N; Schmidt A; Klein C
    Neurology; 2010 Aug; 75(5):478; author reply 478-9. PubMed ID: 20679642
    [No Abstract]   [Full Text] [Related]  

  • 4. SCOPA-cognition cutoff value for detection of Parkinson's disease dementia.
    Verbaan D; Jeukens-Visser M; Van Laar T; van Rooden SM; Van Zwet EW; Marinus J; van Hilten JJ
    Mov Disord; 2011 Aug; 26(10):1881-6. PubMed ID: 21542025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parkinson's disease with dementia (PDD)].
    Takeda A
    Nihon Rinsho; 2011 Dec; 69 Suppl 10 Pt 2():350-5. PubMed ID: 22755212
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychological prediction of dementia in Parkinson's disease.
    Mahieux F; Fénelon G; Flahault A; Manifacier MJ; Michelet D; Boller F
    J Neurol Neurosurg Psychiatry; 1998 Feb; 64(2):178-83. PubMed ID: 9489527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of delusional misidentification syndromes in Parkinson's disease with dementia.
    Pagonabarraga J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Kulisevsky J
    Mov Disord; 2008 Feb; 23(3):443-8. PubMed ID: 18076112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: epidemiology, (differential) diagnosis, therapy, relation to dementia.
    Oertel WH
    Arzneimittelforschung; 1995 Mar; 45(3A):386-9. PubMed ID: 7763330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
    Cormack F; Aarsland D; Ballard C; Tovée MJ
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between Parkinson's disease and dementia. A study using proton NMR imaging parameters.
    Besson JA; Mutch WJ; Smith FW; Corrigan FM
    Br J Psychiatry; 1985 Oct; 147():380-2. PubMed ID: 4075025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 85-year old man with Parkinson's disease accompanying dementia.
    Sakatu M
    Brain Nerve; 2010 Jun; 62(6):635-42. PubMed ID: 20593577
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inferior frontal region hypoperfusion in Parkinson disease with dementia].
    Ochudło S; Opala G; Jasińska-Myga B; Siuda J; Nowak S
    Neurol Neurochir Pol; 2003; 37 Suppl 5():133-44. PubMed ID: 15098340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.
    Mosimann UP; Müri RM; Burn DJ; Felblinger J; O'Brien JT; McKeith IG
    Brain; 2005 Jun; 128(Pt 6):1267-76. PubMed ID: 15774501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing cognition in Parkinson disease: use of the cognitive linguistic quick test.
    Parashos SA; Johnson ML; Erickson-Davis C; Wielinski CL
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):228-34. PubMed ID: 19666882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF somatostatin-like immunoreactivity in dementia of Parkinson's disease.
    Poewe W; Benke T; Karamat E; Schelosky L; Wagner M; Sperk G
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1105-6. PubMed ID: 1981375
    [No Abstract]   [Full Text] [Related]  

  • 17. Distinctive aspects of cognitive dysfunction in Parkinson's disease.
    Growdon JH; Corkin S; Rosen TJ
    Adv Neurol; 1990; 53():365-76. PubMed ID: 1978518
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive screening in Parkinson's disease: Comparison of the Parkinson Neuropsychometric Dementia Assessment (PANDA) with 3 other short scales.
    Gasser AI; Calabrese P; Kalbe E; Kessler J; Rossier P
    Rev Neurol (Paris); 2016 Feb; 172(2):138-45. PubMed ID: 26494570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing predictive biomarkers for dementia of Parkinson's disease.
    Caviness JN; Aarsland D
    Expert Rev Neurother; 2011 Dec; 11(12):1661-3. PubMed ID: 22091589
    [No Abstract]   [Full Text] [Related]  

  • 20. Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.
    Junqué C; Ramírez-Ruiz B; Tolosa E; Summerfield C; Martí MJ; Pastor P; Gómez-Ansón B; Mercader JM
    Mov Disord; 2005 May; 20(5):540-4. PubMed ID: 15645532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.